Connect with us

International

New study suggests alcohol – not cannabis – is the real “gateway” to problematic drug use

Published

em

Listen to this article

A recent study with more than eight thousand young people dispute claims that cannabis is a 'gateway' drug, finding that young people 'overwhelmingly' try alcohol first, followed by tobacco. Researchers Amy M. Cohn and Hoda Elmasry say using cannabis before alcohol or tobacco is "rare" and may even protect against future substance abuse problems.

According to the study, published in the scientific journal “Alcohol and Drug Dependence”, in 2022 just under half of the US population (45%) lived in a state with some form of legal access to cannabis, with the trend towards drug reform. cannabis now spreading to the rest of the world. However, old allegations perpetuate the myth that cannabis is a 'gateway' drug, with concerns that increased use among young people could lead to stronger and potentially high-risk substance use.

In what is believed to be the first study of its kind, the researchers explored the topic in more detail, examining how many young people tried cannabis before alcohol and tobacco and whether this was related to later substance use.

According to the authors “to our knowledge, no studies have examined whether cannabis use before alcohol and tobacco, compared with cannabis use at the same age as alcohol or tobacco, confers a higher risk of reporting current use. of various substances and other drugs”.

Young people 'overwhelmingly' experiment with alcohol before cannabis
The survey found that young people experience alcohol "overwhelmingly" before cannabis or tobacco, and cannabis use before either substance was rare.

The scientists analyzed data from more than 8.000 young people, collected through the study Population Assessment of Tobacco and Health, which recorded whether they had ever used alcohol, cannabis or tobacco and the age at which they first tried them.

They then examined the associations between starting cannabis before, at the same age or after starting to use alcohol or tobacco, with substance use in the last 30 days.

The results showed that trying cannabis first, before alcohol or tobacco, was "relatively uncommon" (only in 6% of cases).

Only 9% of individuals who claimed to have ever used cannabis reported starting cannabis before alcohol and tobacco, but the prevalence of starting cannabis at the same age that alcohol or tobacco was tried for the first time was more common (21,8%).

Furthermore, those who tried cannabis first were less likely to have substance abuse problems when compared to those who tried other substances at the same time.

The authors conclude that “alcohol is overwhelmingly experienced before tobacco or cannabis. Initiation of cannabis before alcohol and tobacco is uncommon and may even protect against future alcohol use.

“Those who started cannabis before alcohol and tobacco appeared less likely to have a broad constellation of substance use and mental health vulnerabilities compared with those who tried cannabis at the same age when they tried at least one other substance. Deterring the initiation of cannabis with various substances can bring benefits to public health”, they state.

Growing Evidence Refutes the “Gateway” Theory
Other studies in this area also contradict the idea that cannabis is a “gateway” drug. Last year, University of Washington researchers found that young people consumed less alcohol, nicotine and over-the-counter pain relievers after cannabis was legalized for adult use.

Investigators assessed trends in the use of alcohol, nicotine, and nonprescription pain relievers among a group of more than 12.500 young adults (ages 18 to 25) in Washington state after legalization in 2012. Contrary to concerns about harmful effects in society at large, according to the study, “the implementation of legalized non-medical cannabis has coincided with the decrease in the use of alcohol and cigarettes and the misuse of painkillers”.
_______________________________________________________________
This article was originally published on CannabisHealth.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Hemp21 hours ago

Italian court suspends ban on CBD oils, but hemp sector protests continue across the country

Italy's embattled hemp industry demonstrated in unison yesterday to protest against the attempted...

Hemp2 days ago

Italy: Hemp Industry Fights Government Crackdown on CBD and Hemp-Derived Cannabinoids

Italy's hemp industry is facing its biggest challenge yet as the government introduces measures...

International2 days ago

Pakistan wants a regulated cannabis industry, but with a 0,3% THC limit

Pakistan is set to establish its own medicinal cannabis industry, with the National Assembly set to vote...

International7 days ago

Volkswagen invests in industrial hemp leather for car interiors

After brands such as Ford, BMW or Mercedes, Volkswagen has started a cooperation with the German start-up Revoltech GmbH...

International7 days ago

Jazz Pharmaceuticals fails Phase 3 Epidyolex clinical trial in Japan

Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...

Press Releases1 weeks ago

UK: Landlords risk breaching Equality Act over prescribed cannabis

Landlords, property managers and housing associations are currently at risk of breaching the Equality Act due to...

International1 weeks ago

USA: New York destroys four tons of cannabis products worth $63 million

City officials in New York City have incinerated more than four tons of unregulated cannabis products...

Events1 weeks ago

Product Earth kicks off in London next weekend

The 9th edition of Product Earth will take place on the 7th and 8th of September, at Drumsheds, in London, United Kingdom...

International1 weeks ago

USA – Legalization did not increase cannabis use, but reduced alcohol consumption and surpassed it

Young Americans are using less cannabis today than in 2014, but for the first time since...

Press Releases1 weeks ago

VertiFarm will showcase the latest technological trends and innovations for cannabis production

International trade fair to provide information on efficient cultivation options for useful, nutritious and health-promoting cannabis products and applications...